Regeneron Pharmaceuticals
A senior regulatory leader at Regeneron overseeing the CMC and Combination Products Internal Medicine function, providing strategic direction for a drug/device portfolio. The role focuses on global regulatory strategy, external engagement with health authorities, and team leadership to advance product development and commercialization.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Director and Regulatory Platform Lead GRA CMC, Device and Drug-Device Combinations Human Factors
BioLife Plasma Services
Director, CMC Regulatory Affairs – Combination Products and Device
Gilead Sciences
Senior Director, Regulatory Affairs CMC
Mirum Pharmaceuticals
Director, CMC Regulatory Affairs
Jobgether
Director, CMC and Device Regulatory Affairs
Apogee Therapeutics
Senior Manager, CMC Regulatory Affairs – Combination Products and Device
Gilead Sciences